Dr. Milan Rohit Sheth, MD

Dr. Sheth practices at Long Beach Medical Center in Long Beach, California, part of MemorialCare Health System.

Dr. Sheth's NPI, 1235217266, was assigned on November 1, 2006. Dr. Sheth graduated from The Flinders University of South Australia School of Medicine in 2001. Dr. Sheth holds California license A89548.

Dr. Sheth's primary practice is Long Beach Medical Center, at 2801 Atlantic Ave, Long Beach, CA 90806 in Los Angeles County. The practice phone is (562) 933-2000.

Dr. Sheth's primary practice is Long Beach Medical Center in Long Beach, California, part of MemorialCare Health System. The medical group on file is MemorialCare Medical Group. Dmand AI also links Dr. Sheth to 2 more group practices and clinics, 1 home health agency, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sheth practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Sheth's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Sheth is board certified in hematology by the American Board of Internal Medicine. Dr. Sheth is licensed in California.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, lymphoma and multiple myeloma among the conditions Dr. Sheth treats.

CMS data shows 1,066 Medicare services from Dr. Sheth across 6 procedure codes in 2024, for 227 Medicare patients. Medicare paid $92,814 for them.

CMS counts 227 Medicare patients who saw Dr. Sheth in 2024. The largest group is 65 to 74, with 90 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sheth's median patient age at 66, with 52% women.

In 2024, Dr. Sheth wrote 297 Medicare Part D claims for 87 patients. 86% of them were for generic drugs. CMS names the drug for 100 of them, across 6 drugs with 11 or more claims each, at $12,352 in total drug cost. In 2023, CMS named 95 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Sheth for performance year 2024, reported as part of a group. Dr. Sheth accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sheth as offering telehealth.

Dmand AI links 1 paper to Dr. Sheth in 2023. Dr. Sheth's most frequent co-authors are Ryan W. Chiu, MD and Jimmy Johannes, MD.

Dmand AI links Dr. Sheth to 4 clinical trials. 2 are still active or recruiting. Conditions studied include Anemia, Iron-Deficiency, Breast Neoplasms, Male and Leukemia, Myeloid, Acute. Open Payments lists research payments to Dr. Sheth that name 1 trial.

CMS Open Payments shows 528 general payments to Dr. Sheth from 55 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 34% of the total. Alexion Pharmaceuticals, Inc. paid the most, $65,099. It also lists 1 research payment totaling $1,298 in 2022, naming 1 clinical trial.

Dr. Sheth graduated from The Flinders University of South Australia School of Medicine in 2001.

Dr. Sheth is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.